Duc T. Duong

Array ( [id] => 14435457 [patent_doc_number] => 20190175600 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2019-06-13 [patent_title] => USAGE AND DOSAGE OF THERAPEUTIC AGENTS FOR ENDOMETRIOSIS [patent_app_type] => utility [patent_app_number] => 16/322227 [patent_app_country] => US [patent_app_date] => 2017-08-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3634 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -4 [patent_words_short_claim] => 40 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16322227 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 16696627 [patent_doc_number] => 10947207 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2021-03-16 [patent_title] => GP130 modulators [patent_app_type] => utility [patent_app_number] => 16/323033 [patent_app_country] => US [patent_app_date] => 2017-08-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 20 [patent_no_of_words] => 29173 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 36 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16323033 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 14088297 [patent_doc_number] => 10240042 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2019-03-26 [patent_title] => Photoluminescent compounds and uses thereof [patent_app_type] => utility [patent_app_number] => 15/661151 [patent_app_country] => US [patent_app_date] => 2017-07-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 13152 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 296 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15661151 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 12016914 [patent_doc_number] => 09809605 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2017-11-07 [patent_title] => 'Broad spectrum beta-lactamase inhibitors' [patent_app_type] => utility [patent_app_number] => 15/656845 [patent_app_country] => US [patent_app_date] => 2017-07-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 13 [patent_no_of_words] => 15756 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 5 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15656845 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 12151420 [patent_doc_number] => 20180022684 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2018-01-25 [patent_title] => 'PROCESS FOR THE PREPARATION OF ESTERS BY MEANS OF CARBONYLATION OF ETHERS' [patent_app_type] => utility [patent_app_number] => 15/651062 [patent_app_country] => US [patent_app_date] => 2017-07-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5760 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15651062 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 13916603 [patent_doc_number] => 10202409 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2019-02-12 [patent_title] => 1, 1' -bis(phosphino)ferrocene ligands for alkoxycarbonylation [patent_app_type] => utility [patent_app_number] => 15/649781 [patent_app_country] => US [patent_app_date] => 2017-07-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7462 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 122 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15649781 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 14342065 [patent_doc_number] => 20190153005 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2019-05-23 [patent_title] => MITOCHONDRIA-TARGETING FLUORESCENT POTASSIUM+ SENSOR AND METHOD OF MAKING THE SAME [patent_app_type] => utility [patent_app_number] => 16/314753 [patent_app_country] => US [patent_app_date] => 2017-07-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6239 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -18 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16314753 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 15634249 [patent_doc_number] => 10590101 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2020-03-17 [patent_title] => Benzo-N-hydroxy amide compounds having antitumor activity [patent_app_type] => utility [patent_app_number] => 16/315576 [patent_app_country] => US [patent_app_date] => 2017-07-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6078 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 103 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16315576 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 14652673 [patent_doc_number] => 20190233465 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2019-08-01 [patent_title] => C7, C12, AND C16 SUBSTITUTED NEUROACTIVE STEROIDS AND THEIR METHODS OF USE [patent_app_type] => utility [patent_app_number] => 16/316851 [patent_app_country] => US [patent_app_date] => 2017-07-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 56573 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -26 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16316851 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 13024515 [patent_doc_number] => 10034869 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2018-07-31 [patent_title] => S1P modulating agents [patent_app_type] => utility [patent_app_number] => 15/644352 [patent_app_country] => US [patent_app_date] => 2017-07-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 35579 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 92 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15644352 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 14342027 [patent_doc_number] => 20190152986 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2019-05-23 [patent_title] => CRYSTAL FORM A OF MILBEMYCIN A3 OXIME AND PREPARATION METHOD THEREOF [patent_app_type] => utility [patent_app_number] => 16/314748 [patent_app_country] => US [patent_app_date] => 2017-07-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3753 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -10 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16314748 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 13106779 [patent_doc_number] => 10072022 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2018-09-11 [patent_title] => Oridonin analogs, compositions, and methods related thereto [patent_app_type] => utility [patent_app_number] => 15/635454 [patent_app_country] => US [patent_app_date] => 2017-06-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 16 [patent_figures_cnt] => 16 [patent_no_of_words] => 22024 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 121 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15635454 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 14467531 [patent_doc_number] => 20190185408 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2019-06-20 [patent_title] => METHOD FOR PRODUCING AROMATIC NITRILE COMPOUND AND METHOD FOR PRODUCING CARBONATE ESTER [patent_app_type] => utility [patent_app_number] => 16/310210 [patent_app_country] => US [patent_app_date] => 2017-06-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 11008 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -12 [patent_words_short_claim] => 25 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16310210 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 11987741 [patent_doc_number] => 20170291895 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2017-10-12 [patent_title] => 'GLS1 INHIBITORS FOR TREATING DISEASE' [patent_app_type] => utility [patent_app_number] => 15/624168 [patent_app_country] => US [patent_app_date] => 2017-06-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 81798 [patent_no_of_claims] => 49 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15624168 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 13748709 [patent_doc_number] => 10167285 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2019-01-01 [patent_title] => Small-molecule HSP90 inhibitors [patent_app_type] => utility [patent_app_number] => 15/620865 [patent_app_country] => US [patent_app_date] => 2017-06-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 18 [patent_figures_cnt] => 45 [patent_no_of_words] => 12400 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 173 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15620865 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 18910323 [patent_doc_number] => 11873292 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2024-01-16 [patent_title] => Trans-indoline cyclopropylamine chemical compound, and method for preparation, pharmaceutical composition, and use thereof [patent_app_type] => utility [patent_app_number] => 16/306751 [patent_app_country] => US [patent_app_date] => 2017-06-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 16439 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 471 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16306751 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 14868311 [patent_doc_number] => 20190284397 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2019-09-19 [patent_title] => PHOTOCHROMIC MULTIPLE RING-FUSED NAPHTHOPYRANS HAVING EXTREME LONGWAVE ABSORPTION EXTENDING FAR INTO THE VISIBLE WAVELENGTH RANGE [patent_app_type] => utility [patent_app_number] => 16/336185 [patent_app_country] => US [patent_app_date] => 2017-05-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3418 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -10 [patent_words_short_claim] => 859 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16336185 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 14993493 [patent_doc_number] => 20190315704 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2019-10-17 [patent_title] => PROTECTION OF PLANT EXTRACTS AND COMPOUNDS FROM DEGRADATION [patent_app_type] => utility [patent_app_number] => 16/300537 [patent_app_country] => US [patent_app_date] => 2017-05-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6264 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -27 [patent_words_short_claim] => 34 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16300537 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 11851638 [patent_doc_number] => 20170226130 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2017-08-10 [patent_title] => 'Ataxia Telengiectasia And Rad3-Related (ATR) Protein Kinase Inhibitors' [patent_app_type] => utility [patent_app_number] => 15/498631 [patent_app_country] => US [patent_app_date] => 2017-04-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 48835 [patent_no_of_claims] => 30 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15498631 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 11834581 [patent_doc_number] => 20170216301 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2017-08-03 [patent_title] => 'NOVEL BICYCLIC BROMODOMAIN INHIBITORS' [patent_app_type] => utility [patent_app_number] => 15/486256 [patent_app_country] => US [patent_app_date] => 2017-04-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 90437 [patent_no_of_claims] => 31 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15486256 [rel_patent_id] =>[rel_patent_doc_number] =>)